I'm trying to explain to you that, actually, the system—. Why should all that be set within a cancer strategy, if, actually, it could be something where there could be implications for stroke? What are we going to do there? Do you separate them out? Do you put everything—? It's about duplication; I think we've got to be very careful not to duplicate different strategies. What we can't hope to improve is cancer outcomes unless we see the recovery and transformation of all of those different services, each of which is subject to important national policy programme support and local planning arrangements.

A similar story could be told for access to surgery, the dominant intervention for curative treatment, and for our vital palliative care services, all of which sit alongside specialist cancer parts of the pathway such as radiotherapy and chemotherapy, which are clearly areas of specialisation for cancer. Once we understand the breadth of the wider services involved in the cancer pathway, then I'll hope you understand why I think we need to take a more nuanced approach.

The quality statement for cancer is not some sort of lightweight delivery plan; it's an entirely new construct that is designed to work within the Welsh context, and its rationale is described in the national clinical framework.